As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Nido, short for Neat Insulin Daily Organiser, makes insulin injections safer and more convenient for persons with diabetes.

Pakistan’s healthcare landscape has entered a pivotal phase in the management of diabetes and obesity. For years, advanced ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...

Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies ISTANBUL, Oct ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

Embecta Corp. company and executive profile by Barron's. View the latest EMBC company infomation and executive bios.